Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea · Delayed Price · Currency is KRW 6,130.00
+30.00 (0.49%)
Mar 13, 2026, 3:30 PM KST
Dongwha Pharm.Co.,Ltd Market Cap
Dongwha Pharm.Co.,Ltd has a market cap or net worth of 169.08 billion as of March 13, 2026. Its market cap has increased by 0.66% in one year.
Market Cap
169.08B
Enterprise Value
292.75B
Revenue
493.33B
Ranking
n/a
PE Ratio
22.29
Stock Price
6,130.00
Market Cap Chart
Since August 28, 1995, Dongwha Pharm.Co.,Ltd's market cap has increased from 72.32B to 169.08B, an increase of 133.78%. That is a compound annual growth rate of 2.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 169.08B | -2.40% |
| Dec 30, 2025 | 173.24B | -0.79% |
| Dec 30, 2024 | 174.62B | -38.57% |
| Dec 28, 2023 | 284.26B | 10.91% |
| Dec 29, 2022 | 256.31B | -36.58% |
| Dec 30, 2021 | 404.12B | -25.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 209.65B |
| Samil Pharmaceutical Co.,Ltd | 207.84B |
| JW Lifescience | 200.37B |
| AptaBio Therapeutics | 193.84B |
| REYON Pharmaceutical | 191.30B |
| Daihan Pharmaceutical | 172.58B |
| SAMSUNG PHARM. Co., LTD. | 169.42B |
| Hana Pharm | 168.49B |